AOD 9604/ CJC-1295/ Ipamorelin 12mg Blend
AOD 9604/ CJC-1295/ Ipamorelin 12mg Blend
AOD 9604 / CJC-1295 / Ipamorelin 12mg Blend — Research Grade
This research blend combines three peptides — AOD 9604, CJC-1295, and Ipamorelin — into a single 12mg formulation. AOD 9604 is a 16-amino acid fragment of human growth hormone studied for fat metabolism and lipolysis. CJC-1295 is a GHRH analogue that stimulates pulsatile GH release, and Ipamorelin is a selective GHRP that amplifies GH secretion without elevating cortisol. Together, they are studied for their synergistic effects on GH axis activation and metabolic regulation. This product is supplied in lyophilized (powder) form and is intended strictly for in vitro and laboratory research purposes.
Key Research Areas
- Synergistic GH axis activation via GHRH and GHRP pathways
- Fat metabolism, lipolysis, and adipose tissue reduction (AOD 9604)
- Pulsatile GH secretion and IGF-1 regulation (CJC-1295)
- Selective GH release without cortisol elevation (Ipamorelin)
- Body composition and metabolic optimization research
Product Details
- Total Concentration: 12mg blend (AOD 9604 / CJC-1295 / Ipamorelin)
- Purity: Research grade
- Format: Lyophilized powder
- Storage: Store at -20°C; protect from light and moisture
- Reconstitution: Recommended with bacteriostatic water
For research use only. Not intended for human or veterinary use. This product has not been evaluated by the FDA and is not approved for therapeutic or diagnostic use.